Urinary BLCA-4 is highly specific for detection of bladder cancer in chinese han population and is related to tumour invasiveness

Folia Biologica (Czech Republic)

Volumn 57, Issue 6, 2011, Pages 242-247

  Feng, C C ^a   Wang, P H ^a,b   Guan, M ^b   Jiang, H W ^a   Wen, H ^a   Ding, Q ^a   Wu, Z ^a  

^a Department of Urology ^*  (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BLCA 4 PROTEIN; NUCLEAR PROTEIN; UNCLASSIFIED DRUG; BLCA 4 PROTEIN, HUMAN; BLCA-4 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; ARTICLE; BLADDER CANCER; CANCER DIAGNOSIS; CANCER INVASION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; URINALYSIS; URINARY TRACT INFECTION; UROTHELIUM; AGED; ASIAN; BLADDER TUMOR; CHINA; ETHNIC GROUP; MIDDLE AGED; PATHOLOGY; SENSITIVITY AND SPECIFICITY; URINE; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BLOTTING, WESTERN; CHINA; ETHNIC GROUPS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NUCLEAR PROTEINS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 84863889853     PISSN: 00155500     EISSN: 25337602     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. AUA Clinical Guidelines, Bladder Cancer (2010) http://www.auanet.org/ content/guidelines-and-quality-care/clinicalguidelines/main-reports/bladcan07/ chapter1.pdf
2. Babjuk, M., Oosterlinck, W., Sylvester, R., Kassinen, E., Bohle, A., Palou, J. (2008) EAU guidelines on non-muscle invasive urothelial carcinoma of the bladder. Eur. Urol. 54, 303-314
3. Botteman, M. F., Pashos, C. L., Redaelli, A., Laskin, B., Hauser, R. (2003) The health economics of bladder cancer: a comprehensive review of the published literature. Pharmacoeconomics 21, 1315-1330
4. Feng, C., Guan, M., Ding, Q., Zhang, Y., Jiang, H., Wen, H., Wang, P., Wu, Z. (2011a) Expression of pigment epithelium-derived factor in bladder tumour is correlated with interleukin-8 yet not with interleukin-1α. J. Huazhong. Univ. Sci. Technol. Med. Sci. 31, 21-25.
5. Feng, C., Wang, P., Ding, Q., Guan, M., Zhang, Y., Jiang, H., Wen, H., Wu, Z. (2011b) Expression of pigment epithelium-derived factor and tumor necrosis factor-α is correlated in bladder tumor and is related to tumor angiogenesis. Urol. Oncol. doi:10.1016/j.urolonc.2010.12.001.
6. Gaston, K. E., Grossman, H. B. (2010) Proteomic assays for the detection of urothelial cancer. Methods Mol. Biol. 641, 303-323.
7. Getzenberg, R. H., Konety, B. R., Oeler, T. A., Quigley, M. M., Hakam, A., Becich, M. J., Bahnson, R. R. (1996) Bladder cancer-associated nuclear matrix proteins. Cancer Res. 56, 1690-1694.
8. Habuchi, T., Marberger, M., Droller, M. J., Hemstreet, G. P. III, Grossman, H. B., Schalken, J. A., Schmitz-Drager, B. J., Murphy, W. M., Bono, A. V., Goebell, P., Getzenberg, R. H., Hautmann, S. H., Messing, E., Fradet, Y., Lokeshwar, V. B. (2005) Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers. Urology 66, 64-74.
9. Konety, B. R., Nguyen, T. S., Dhir, R., Day, R. S., Becich, M. J., Stadler, W. M., Getzenberg, R. H. (2000a) Detection of bladder cancer using a novel nuclear matrix protein, BLCA-4. Clin. Cancer Res. 6, 2618-2625.
10. Konety, B. R., Nguyen, T. S., Brenes, G., Sholder, A., Lewis, N., Bastacky, S., Potter, D. M., Getzenberg, R.H. (2000b) Clinical usefulness of the novel marker BLCA-4 for the detection of bladder cancer. J. Urol. 164, 634-639.
11. Lamm, D. L. (2000) The challenge of improved diagnostic and prognostic indicators of superficial bladder cancer. J. Urol. 164, 690-691
12. Myers-Irvin, J. M., Van Le, T. S., Getzenberg, R. H. (2005a) Mechanistic analysis of the role of BLCA-4 in bladder cancer pathobiology. Cancer Res. 65, 7145-7150.
13. Myers-Irvin, J. M., Landsittel, D., Getzenberg, R. H. (2005b) Use of the novel marker BLCA-1 for the detection of bladder cancer. J. Urol. 174, 64-68.
14. Rosai, E. J. (2004) Rosai and Ackerman's Surgical Pathology, vol. 1, 9th ed., pp. 137-1359, Elsevier, China.
15. Shirodkar, S. P., Lokeshwar, V. B. (2009) Potential new urinary markers in the early detection of bladder cancer. Curr. Opin. Urol. 19, 488-493.
16. Surveillance Epidemiology and End Results Database (2010) http://seer.cancer.gov
17. Van Le, T. S., Myers, J., Konety, B. R., Barder, T., Getzenberg, R. H. (2004) Functional characterization of the bladder cancer marker, BLCA-4. Clin. Cancer Res. 10, 1384-1391.
18. Van Le, T. S., Miller, R., Barder, T., Babjuk, M., Potter, D. M., Getzenberg, R. H. (2005) Highly specific urine-based marker of bladder cancer. Urology 66, 1256-1260.
19. Yossepowitch, O., Herr, H. W., Donat, S. M. (2007) Use of urinary biomarkers for bladder cancer surveillance: patient perspectives. J. Urol. 177, 1277-1282.
20. World Health Organization Classification of Tumours, Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs (2004) eds. Eble, J. N., Sauter, G., Epstein, J. I., Sesterhenn, I. A., pp. 90-109, IARC Press, Lyon.